Reminder App to Optimize Bladder Filling During Radiotherapy for Prostate Cancer

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age18+
SponsorUniversity Hospital Schleswig-Holstein

About this trial

The primary goal of this study is to assess the impact of an app that reminds patients irradiated for high-risk prostate cancer to drink water prior to each radiotherapy session on the number of bladder volumes \<200 ml during the radiotherapy course and to demonstrate that this number is lower than without using an app (historical control group).

Eligibility criteria

Qualifiers

Histologically proven high-risk prostate cancer

Indication for definitive normo-fractionated radiotherapy

Possession of a smart phone and the ability to use it

Bladder volume at CT-simulation <200 ml

Disqualifiers

Radiotherapy of pelvic lymph nodes

Expected non-compliance

Trial design

Treatments tested in this trial

  • Reminder App

Treatment groups

28 Participants
are divided into 1 treatment group

Sponsors and collaborators

University Hospital Schleswig-Holstein

Lead sponsor

University of Southern Denmark

Collaborator

Medical School Hamburg

Collaborator